Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography
- PMID: 20529972
- DOI: 10.1177/0003319710373093
Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography
Abstract
The present work aimed to prove the usage of neutrophil gelatinase-associated lipocalin (NGAL) as an early biomarker for kidney injury and to assess the relationship between NGAL and serum creatinine and cystatin C in patients with normal serum creatinine undergoing percutaneous coronary angiography. Thirty patients with normal serum creatinine undergoing coronary angiography were enrolled. Estimation of blood glucose, glycosylated hemoglobin, lipid profile, creatinine, NGAL, and cystatin C were done before coronary angiography for all patients. Serum creatinine, NGAL and cystatin C were evaluated again at 4 and 24 hours after coronary angiography. There was a significant increase in serum NGAL level 4 hours and 24 hours after coronary interventions compared to the baseline value before coronary angiography. Before coronary angiography, serum NGAL was positively correlated with serum creatinine, and cystatin C.
Conclusion: Serum NGAL and cystatin C could be valuable in the detection of early renal impairment after coronary angiography.
Comment in
-
Contrast-induced nephropathy and the vascular patient.Angiology. 2010 Nov;61(8):721-3. doi: 10.1177/0003319710379110. Epub 2010 Aug 3. Angiology. 2010. PMID: 20682609 Review. No abstract available.
Similar articles
-
Serum neutrophil gelatinase associated lipocalin (NGAL) and cystatin C as early predictors of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.Clin Chim Acta. 2014 Aug 5;435:48-52. doi: 10.1016/j.cca.2014.04.016. Epub 2014 May 5. Clin Chim Acta. 2014. PMID: 24804935
-
Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.Angiology. 2014 May;65(5):436-42. doi: 10.1177/0003319713483918. Epub 2013 Apr 11. Angiology. 2014. PMID: 23580616
-
Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention.Chin Med J (Engl). 2012 Mar;125(6):1051-6. Chin Med J (Engl). 2012. PMID: 22613530
-
Novel Biomarkers of Acute Kidney Injury After Contrast Coronary Angiography.Cardiol Rev. 2015 Sep-Oct;23(5):240-6. doi: 10.1097/CRD.0000000000000058. Cardiol Rev. 2015. PMID: 25699983 Review.
-
Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography.Ren Fail. 2014 Jul;36(6):979-86. doi: 10.3109/0886022X.2014.900429. Epub 2014 Mar 27. Ren Fail. 2014. PMID: 24673459 Review.
Cited by
-
The Prognostic Utility of Plasma NGAL Levels in ST Segment Elevation in Myocardial Infarction Patients.Adv Prev Med. 2020 Aug 30;2020:4637043. doi: 10.1155/2020/4637043. eCollection 2020. Adv Prev Med. 2020. PMID: 32908709 Free PMC article.
-
Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature.Diab Vasc Dis Res. 2021 Nov-Dec;18(6):14791641211058856. doi: 10.1177/14791641211058856. Diab Vasc Dis Res. 2021. PMID: 34791910 Free PMC article. Review.
-
A novel risk factor of contrast associated acute kidney injury in patients after enhanced computed tomography: a retrospective study.PeerJ. 2022 Oct 20;10:e14224. doi: 10.7717/peerj.14224. eCollection 2022. PeerJ. 2022. PMID: 36285330 Free PMC article.
-
Effects of Serum Cytochrome c on Contrast-Induced Nephropathy in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.Biomed Res Int. 2019 Jan 23;2019:9357203. doi: 10.1155/2019/9357203. eCollection 2019. Biomed Res Int. 2019. PMID: 30809550 Free PMC article.
-
Comparative analysis of four established risk scores for predicting contrast induced acute kidney injury after primary percutaneous coronary interventions.Int J Cardiol Heart Vasc. 2021 Oct 29;37:100905. doi: 10.1016/j.ijcha.2021.100905. eCollection 2021 Dec. Int J Cardiol Heart Vasc. 2021. PMID: 34765719 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous